BGB-11417

A Phase 1b/2, Open-Label, Dose Finding, and Expansion Study of the Bcl-2 Inhibitor BGB-11417 in Patients With Myeloid Malignancies

Arms / Cohorts

Experimental:Parts 1 and 2: AML Cohorts

Accepting patients

Experimental:Parts 1 and 2: MDS Cohorts

Accepting patients

Experimental:Part 3: AML and MDS Cohorts

Accepting patients

Experimental:Part 3: AML and MDS Cohort

Accepting patients

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print Report

Print a patient-friendly report to share with your patient.

(888) 803-1766

We can help answer any questions and connect you (or your patient) with the study team.

Schedule Call

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.